相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model
Arianne van Koppen et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
Cristina Alonso et al.
GASTROENTEROLOGY (2017)
Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice
I. A. C. Arnoldussen et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Targeting hepatic macrophages to treat liver diseases
Frank Tacke
JOURNAL OF HEPATOLOGY (2017)
The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications
Anna Alisi et al.
MEDIATORS OF INFLAMMATION (2017)
A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice
Marieke H. Schoemaker et al.
PLOS ONE (2017)
Role of Aramchol in Steatohepatitis and Fibrosis in Mice
Marta Iruarrizaga-Lejarreta et al.
HEPATOLOGY COMMUNICATIONS (2017)
Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin
Philippe Lefebvre et al.
JCI INSIGHT (2017)
Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications
Ramesh Kumar et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2017)
CAT-2003: A Novel Sterol Regulatory Element-Binding Protein Inhibitor That Reduces Steatohepatitis, Plasma Lipids, and Atherosclerosis in Apolipoprotein E*3-Leiden Mice
Michael Zimmer et al.
HEPATOLOGY COMMUNICATIONS (2017)
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
Samar H. Ibrahim et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development - a potential therapeutic target?
Paola Dongiovanni et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease
Yoosoo Chang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients
Andreas Teufel et al.
GASTROENTEROLOGY (2016)
Pathogenesis of Nonalcoholic Steatohepatitis
Mariana Verdelho Machado et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice
M. C. Morrison et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Non-alcoholic fatty liver disease and dyslipidemia: An update
Niki Katsiki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Immunology in the liver - from homeostasis to disease
Felix Heymann et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Heatmapper: web-enabled heat mapping for all
Sasha Babicki et al.
NUCLEIC ACIDS RESEARCH (2016)
Reduction of obesity-associated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice
Petra Mulder et al.
SCIENTIFIC REPORTS (2016)
Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
Mohammad S. Siddiqui et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Altered Hepatic Gene Expression in Nonalcoholic Fatty Liver Disease Is Associated With Lower Hepatic n-3 and n-6 Polyunsaturated Fatty Acids
Bianca M. Arendt et al.
HEPATOLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE*3Leiden mice
Martine C. Morrison et al.
JOURNAL OF HEPATOLOGY (2015)
Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease
Bharat K. Puchakayala et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease
Cynthia A. Moylan et al.
HEPATOLOGY (2014)
The Portal Inflammatory Infiltrate and Ductular Reaction in Human Nonalcoholic Fatty Liver Disease
Victoria L. Gadd et al.
HEPATOLOGY (2014)
Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
Akinobu Takaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology
Wen Liang et al.
PLOS ONE (2014)
DNA Methylation Analysis in Nonalcoholic Fatty Liver Disease Suggests Distinct Disease-Specific and Remodeling Signatures after Bariatric Surgery
Markus Ahrens et al.
CELL METABOLISM (2013)
The global NAFLD epidemic
Rohit Loomba et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans
Michiko Itoh et al.
PLOS ONE (2013)
Inflammation and fibrogenesis in steatohepatitis
Hideki Fujii et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Systematic Analysis of the Gene Expression in the Livers of Nonalcoholic Steatohepatitis: Implications on Potential Biomarkers and Molecular Pathological Mechanism
Yida Zhang et al.
PLOS ONE (2012)
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation
Ying Li Silvia Innocentin et al.
CELL (2011)
Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients with Nonalcoholic Steatohepatitis
Maria Eugenia Inzaugarat et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Animal models of nonalcoholic fatty liver disease
Lionel Hebbard et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal
Naim Alkhouri et al.
Expert Review of Gastroenterology & Hepatology (2009)
lumi:: a pipeline for processing Illumina microarray
Pan Du et al.
BIOINFORMATICS (2008)
Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis
Nora Anderson et al.
PHARMACOLOGICAL REVIEWS (2008)
A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease
ZM Younossi et al.
HEPATOLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
limmaGUI: A graphical user interface for linear modeling of microarray data
JM Wettenhall et al.
BIOINFORMATICS (2004)